PHARMACOKINETICS OF FLUORIDE IN MAN AFTER SINGLE AND MULTIPLE ORAL DOSES

被引：94

作者：

EKSTRAND, J

ALVAN, G

BOREUS, LO

NORLIN, A

机构：

[1] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN

[2] KAROLINSKA INST,DEPT CARIOL,S-10401 STOCKHOLM 60,SWEDEN

[3] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,S-10401 STOCKHOLM,SWEDEN

[4] HUDDINGE HOSP,DEPT CLIN PHARMACOL,HUDDINGE,SWEDEN

来源：

关键词：

D O I：

10.1007/BF00607432

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：311 / 317

页数：7

共 17 条

[1] ADLER P, 1970, FLUORIDES HUMAN HLTH, P323
[2] ARMSTRONG WD, 1970, FLUORIDES HUMAN HLTH, P93
[3] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
BOXENBAU.HG
RIEGELMA.S
ELASHOFF, RM
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
[4] UTILIZATION OF FLUORIDE TO TREAT OSTEOPOROSIS
DAMBACHER, MA
HAAS, HG
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (13) : 504 - 506
[5] ABSENCE OF PROTEIN-BOUND FLUORIDE FROM HUMAN-BLOOD PLASMA
EKSTRAND, J
ERICSSON, Y
ROSELL, S
[J]. ARCHIVES OF ORAL BIOLOGY, 1977, 22 (04) : 229 - 232
[6] MICROMETHOD FOR DETERMINATION OF FLUORIDE IN BLOOD-PLASMA AND SALIVA
EKSTRAND, J
[J]. CALCIFIED TISSUE RESEARCH, 1977, 23 (03): : 225 - 228
[7] EKSTRAND J, IN PRESS
[8] Ericsson Y., 1973, INT RES COMMUN SYSTE, V1, P33
[9] FORRESTER DJ, 1974, INT WORKSHOP FLUORID, P25
[10] 3 YEARS EXPERIENCE WITH SODIUM-FLUORIDE THERAPY OF OSTEOPOROSIS
FRANKE, J
REMPEL, H
FRANKE, M
[J]. ACTA ORTHOPAEDICA SCANDINAVICA, 1974, 45 (01): : 1 - 20